927 LONG TERM RESULTS AFTER CNS RELAPSE IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

Evaluation of bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia

Background: The purpose of this study was to evaluate long-term changes in bone density profile among survivors of childhood acute lymphoblastic leukemia. Patients and Methods: This was a 5 year prospective study comprised of thirty-one survivors of childhood acute lymphoblastic leukemia with a mean age of 11.8 (4.6) years, who completed therapy at least 1 year previously (according to the ...

Survival after relapse in childhood acute lymphoblastic leukemia.

NS One of the most important prognostic factors in childhood ALL is the age of presentation. Patients who present between the ages of 1 and 10 years have the best prognosis, whereas infants tend to have a very poor prognosis. Improvements are being observed within the adolescent age group. The other main prognostic factor is the level of the patient’s white blood count upon presentation. Patien...

Evaluation of Relationship between Minimal Residual Disease (MRD) and Relapse in Childhood Acute Lymphoblastic Leukemia (ALL) Using Quantitative Fluorescent PCR

Late relapse in a case of childhood acute lymphoblastic leukemia.

A 14-year-old boy presented first at the age of 5 years in May 1985 with complaints of low backache for 3.5 months, fever for 3 weeks and epistaxis for 10 days. The child was found to have marked pallor, sternal tenderness with no significant lymphadenopathy. No hepatosplenomegaly was found. He had a hemoglobin of 95 g/L; total leukocyte count (TLC) 5000/mm and platelets 60,000/mm with a normal...

evaluation of bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia

background: the purpose of this study was to evaluate long-term changes in bone density profile among survivors of childhood acute lymphoblastic leukemia. patients and methods: this was a 5 year prospective study comprised of thirty-one survivors of childhood acute lymphoblastic leukemia with a mean age of 11.8 (4.6) years, who completed therapy at least 1 year previously (according to the all-...